These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26503820)

  • 1. Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.
    Fricke-Galindo I; Céspedes-Garro C; Rodrigues-Soares F; Naranjo ME; Delgado Á; de Andrés F; López-López M; Peñas-Lledó E; LLerena A
    Pharmacogenomics J; 2016 Apr; 16(2):113-23. PubMed ID: 26503820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
    LLerena A; Naranjo ME; Rodrigues-Soares F; Penas-LLedó EM; Fariñas H; Tarazona-Santos E
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1569-83. PubMed ID: 25316321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.
    Céspedes-Garro C; Fricke-Galindo I; Naranjo ME; Rodrigues-Soares F; Fariñas H; de Andrés F; López-López M; Peñas-Lledó EM; LLerena A
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1893-905. PubMed ID: 26595139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.
    Kaneko A; Lum JK; Yaviong L; Takahashi N; Ishizaki T; Bertilsson L; Kobayakawa T; Björkman A
    Pharmacogenetics; 1999 Oct; 9(5):581-90. PubMed ID: 10591538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of CYP2C19*2 and CYP2C19*3 polymorphisms in Venezuelan populations with different admixture.
    Castro de Guerra D; Flores S; Izaguirre MH
    Ann Hum Biol; 2013 Mar; 40(2):197-200. PubMed ID: 23249123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.
    Saldaña-Cruz AM; León-Moreno LC; Sánchez-Corona J; Santiago DA; Mendoza-Carrera F; Castro-Martínez XH; García-Zapién AG; Morán-Moguel MC; Flores-Martínez SE
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):702-709. PubMed ID: 27617498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.
    Jakovski K; Nestorovska AK; Labacevski N; Dimovski AJ
    Pharmazie; 2013 Nov; 68(11):893-8. PubMed ID: 24380239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population.
    de Andrés F; Altamirano-Tinoco C; Ramírez-Roa R; Montes-Mondragón CF; Dorado P; Peñas-Lledó EM; LLerena A
    Pharmacogenomics J; 2021 Apr; 21(2):140-151. PubMed ID: 33024249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population.
    Tayeb HT; Bakheet DH; Zaza K; Wakil SM; Dzimiri N
    J Pharm Pharmacol; 2015 Jul; 67(7):972-9. PubMed ID: 25684066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study.
    Luo HR; Poland RE; Lin KM; Wan YJ
    Clin Pharmacol Ther; 2006 Jul; 80(1):33-40. PubMed ID: 16815315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs).
    Kuhlmann JB; Wensing G; Kuhlmann J
    Int J Clin Pharmacol Ther; 2014 Feb; 52(2):143-50. PubMed ID: 24361088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe.
    Petrović J; Pešić V; Lauschke VM
    Eur J Hum Genet; 2020 Jan; 28(1):88-94. PubMed ID: 31358955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.
    Liu T; Yin T; Li Y; Song LQ; Yu J; Si R; Zhang YM; He Y; Guo WY; Wang HC
    Coron Artery Dis; 2014 Aug; 25(5):412-20. PubMed ID: 24608794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications.
    Biswas M
    Pharmacogenomics J; 2021 Apr; 21(2):190-199. PubMed ID: 33082528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C19 gene polymorphism in Ningxia.
    Yang Z; Xie Y; Zhang D; Zou Y; Li X; Chen R; Zhang X; Chen S; Bai F
    Pharmacol Rep; 2023 Jun; 75(3):705-714. PubMed ID: 36913175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CYP2C19 Polymorphisms on the Platelet Response to Clopidogrel and Influence on the Effect of High Versus Standard Dose Clopidogrel in Carotid Artery Stenting.
    González A; Moniche F; Cayuela A; García-Lozano JR; Torrecillas F; Escudero-Martínez I; Gonzalez-Marcos JR; Mayol A; Montaner J
    Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):175-86. PubMed ID: 26526111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.